SCHEMBL18397358

SCHEMBL18397358

COc1ccc(COc2ccc(Br)cc2O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.57
MAOB P27338 3/20 0.51
LRRK2 Q5S007 2/20 0.50
MAOA P21397 2/20 0.49
TUBB4A P04350 2/20 0.49
TUBB P07437 2/20 0.49
TUBA3C P0DPH7 2/20 0.49
TUBA1B P68363 2/20 0.49
TUBA4A P68366 2/20 0.49
TUBB4B P68371 2/20 0.49
TUBB3 Q13509 2/20 0.49
TUBB2A Q13885 2/20 0.49
TUBB8 Q3ZCM7 2/20 0.49
TUBA3E Q6PEY2 2/20 0.49
TUBA1A Q71U36 2/20 0.49
TUBA1C Q9BQE3 2/20 0.49
TUBB6 Q9BUF5 2/20 0.49
TUBB2B Q9BVA1 2/20 0.49
TUBB1 Q9H4B7 2/20 0.49
SMPD1 P17405 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29858839 1.00 CCR5 (0.57) CCR5MAOBLRRK2MAOATUBB4A
SCHEMBL30133848 0.88 CCR5 (0.54) CCR5MAOBLRRK2MAOASMPD1
SCHEMBL25180595 0.86 CCR5 (0.57) CCR5MAOBLRRK2SMPD1PTGER1
SCHEMBL3931258 0.84 CCR5 (0.56) CCR5MAOBLRRK2SMPD1PTGER1
SCHEMBL30682049 0.84 CCR5 (0.56) CCR5MAOBLRRK2SMPD1PTGER1
SCHEMBL1015213 0.82 CCR5 (0.54) CCR5MAOBLRRK2PTGER1ALDH1A1
SCHEMBL22265052 0.82 CCR5 (0.57) CCR5MAOBLRRK2SMPD1PTGER1
SCHEMBL31320986 0.82 CCR5 (0.57) CCR5MAOBLRRK2SMPD1PTGER1
SCHEMBL1646591 0.81 LRRK2 (0.61) CCR5MAOBLRRK2MAOASMPD1
SCHEMBL2384629 0.81 USP28 (0.56) CCR5MAOBLRRK2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION 2025-12-23 US disclosed
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2024-07-04 US disclosed
EP-3914256-B1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES INC (US) 2024-05-29 EP disclosed
US-11773101-B2 GPR35 modulators PROMETHEUS BIOSCIENCES, INC. (US) 2023-10-03 US disclosed
US-11773101-B2 GPR35 modulators PROMETHEUS BIOSCIENCES, INC. (US) 2023-10-03 US disclosed
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2022-12-15 US disclosed
CN-107922396-B Colony stimulating factor-1 receptor (CSF-1R) inhibitors 建新公司 2022-08-05 CN disclosed
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION (US) 2022-03-15 US disclosed
US-20210380590-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. 2021-12-09 US disclosed
EP-3914256-A1 GPR35 MODULATORS Prometheus Biosciences, Inc. (US) 2021-12-01 EP disclosed
CN-113631168-A GPR35 modulators 普罗米修斯生物科学公司 2021-11-09 CN disclosed
US-11053251-B2 GPR35 modulators PROMETHEUS BIOSCIENCES, INC. (US) 2021-07-06 US disclosed
WO-2020154492-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. (US) 2020-07-30 WO disclosed
WO-2020154492-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. (US) 2020-07-30 WO disclosed
US-20200239476-A1 GPR35 MODULATORS PROMETHEUS BIOSCIENCES, INC. 2020-07-30 US disclosed
US-20190016707-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION 2019-01-17 US disclosed
EP-3325471-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS Genzyme Corporation (US) 2018-05-30 EP disclosed
WO-2017015267-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2017-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN CCR5 136/4885MAOB 3805/4885LRRK2 1015/4885
US-20210380590-A1 GPR35 MODULATORS GPR35, GPR55, GPR65 CCR5 643/4885MAOB 3593/4885LRRK2 2576/4885
US-11053251-B2 GPR35 modulators GPR35, GPR55, GPR65 CCR5 643/4885MAOB 3593/4885LRRK2 2576/4885
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN CCR5 136/4885MAOB 3805/4885LRRK2 1015/4885
US-11773101-B2 GPR35 modulators GPR35, GPR55, GPR65 CCR5 643/4885MAOB 3593/4885LRRK2 2576/4885
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN CCR5 136/4885MAOB 3805/4885LRRK2 1015/4885
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN CCR5 108/4885MAOB 4117/4885LRRK2 735/4885
US-20200239476-A1 GPR35 MODULATORS GPR35, GPR55, GPR65 CCR5 643/4885MAOB 3593/4885LRRK2 2576/4885
US-20190016707-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN CCR5 136/4885MAOB 3805/4885LRRK2 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.